OQS
LJPC

Occudo Quantitative Strategies’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Occudo Quantitative Strategies’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-13,541
Closed -$58K – 1483
2022
Q1 		$58K Sell
13,541
-3,635
-21% -$15.8K ﹤0.01% 1073
2021
Q4 		$80K Sell
17,176
-712
-4% -$2.97K 0.01% 979
2021
Q3 		$71K Sell
17,888
-207
-1% -$822 0.01% 951
2021
Q2 		$77K Sell
18,095
-18
-0.1% -$77 0.01% 820
2021
Q1 		$77K Buy
+18,113
New +$99.8K 0.02% 706

Other funds holding LJPC

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $310M AUM 37.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KT
Kevin Tang $783 AUM 75.59% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Occudo Quantitative Strategies's LJPC Position: Q2 2022 in Review

Occudo Quantitative Strategies sold out of La Jolla Pharmaceutical Company (LJPC) in Q2 2022, closing a stake of 13,541 shares — an estimated $58K sold.

Occudo Quantitative Strategies first reported a position in LJPC in Q1 2021 and held it in 5 quarters. The position peaked at $80K in Q4 2021. 41 funds tracked by Wall St. Rank hold LJPC as of Q2 2022.

  • Occudo Quantitative Strategies reported no remaining La Jolla Pharmaceutical Company position as of Q2 2022 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 13,541 La Jolla Pharmaceutical Company shares in Q2 2022, an estimated $58K.
  • Occudo Quantitative Strategies first reported a position in La Jolla Pharmaceutical Company in Q1 2021 and held it in 5 quarters.
  • Occudo Quantitative Strategies's La Jolla Pharmaceutical Company position peaked at $80K in Q4 2021.
  • 41 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q2 2022.

Based on Occudo Quantitative Strategies's 13F filing for Q2 2022, filed 15 Aug 2022.